AMPD3
MOLECULAR TARGETadenosine monophosphate deaminase 3
AMPD3 (adenosine monophosphate deaminase 3) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting AMPD3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Coformycin | 0.69 | 1 |
About AMPD3 as a Drug Target
AMPD3 (adenosine monophosphate deaminase 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented AMPD3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
AMPD3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.